In this analysis of baseline data from the SMART-Finder study, the primary objective was to assess the proportion of patients with T2DM who had an elevated UACR (≥30 mg/g; albumin-to-creatinine ratio [ACR] stages A2 and A3). Here, ALB is linked to type 2 diabetes mellitus.